Showing results (481-490 of 576) with videos related to

Sort By:
Pageof 58
Annals of Surgery|July 6, 2019
Metabolic Systems Analysis of Shock-Induced Endotheliopathy (SHINE) in Trauma: A New Research ParadigmHanne H Henriksen, Sarah McGarrity, Rósa S SigurÐardóttir, et al.
Journal of Translational Medicine|April 19, 2015
Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patientsElaheh Rahbar, Jessica C Cardenas, Gyulnar Baimukanova, et al.
AIDS (London, England)|July 12, 2013
Discrepant coagulation profile in HIV infection: elevated D-dimer but impaired platelet aggregation and clot initiationAnna K Haugaard, Tamara T Lund, Carsten Birch, et al.
Pharmacogenetics|January 14, 2000
Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotypeA Wennerholm, I Johansson, A Y Massele, et al.
Blood Cancer Journal|July 16, 2016
Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cellsK K Starheim, T Holien, K Misund, et al.
The Journal of Surgical Research|December 17, 2014
Fibrinogen in trauma, an evaluation of thrombelastography and rotational thromboelastometry fibrinogen assaysMartin A S Meyer, Sisse R Ostrowski, Anne Marie Sørensen, et al.
The Journal of Surgical Research|April 4, 2014
Treatment with a histone deacetylase inhibitor, valproic acid, is associated with increased platelet activation in a large animal model of traumatic brain injury and hemorrhagic shockSimone E Dekker, Martin Sillesen, Ted Bambakidis, et al.
Current Opinion in Anaesthesiology|June 2, 2021
Getting hit by the bus around the world - a global perspective on goal directed treatment of massive hemorrhage in traumaStephan Johannsen, Karim Brohi, Pär I Johansson, et al.
Transplant Immunology|December 20, 2023
sVEGF-R1 in acute non-infectious toxicity syndromes after pediatric allogeneic hematopoietic stem cell transplantationDenise Elbæk Horan, Katrine Kielsen, Sarah Wegener Weischendorff, et al.
Clinical Pharmacology and Therapeutics|November 3, 1998
Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotypeK Herrlin, A Y Massele, M Jande, et al.
Pageof 58